FDA Adverse Event Malfunction Summary report: N

DATALINK/DL2000 DATA MANAGER, COMMAND CENTRAL

MDR report key: 2172090 · Received June 15, 2011

Report

Report Number
2050012-2011-02178
Event Type
Malfunction
Date Received
June 15, 2011
Date of Event
September 24, 2008
Report Date
September 24, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
JQP
PMA / PMN Number
EXEMPT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A BCI HOTLINE CUSTOMER SERVICE REP CONFIRMED THAT THE CUSTOMER HAD INCORRECTLY CONFIGURED THE RULE ON THE DL2000 TO CHANGE ANY CRP RESULT THAT CONTAINS "DL" TO "<0.5." THE HOTLINE ASSISTED THE CUSTOMER TO CORRECT THE CONFIGURATION OF THE RULE AND ADVISED THAT ALL OTHER CONFIGURATIONS SHOULD BE CHECKED. THIS REPORTABLE EVENT WAS IDENTIFIED DURING A RETROSPECTIVE REVIEW OF COMPLAINTS CONDUCTED BETWEEN JANUARY 1, 2008 TO OCTOBER 23, 2010 FOR ADDITIONAL REPORTABLE EVENTS.

Description of Event or Problem · 1

THE CUSTOMER CONTACTED BECKMAN COULTER, INCORPORATED (BCI), AND REPORTED THAT THEY OBTAINED AN ERRONEOUSLY LOW READING OF "< 0.5 MG/DL" FOR CRP (C-REACTIVE PROTEIN) FOR ONE PT FROM THE DATALINK/DL2000 DATA MANAGER SYSTEM WHICH WAS CONNECTED TO THE DXC INSTRUMENT. THE DXC INSTRUMENT HAD UPLOADED A BH DL (BLANK HIGH, DYNAMIC LOW) SUPPRESSED ERROR CODE FOR CRP TO THE DL2000 CONSOLE AND UPON RECOGNIZING THIS FLAG, THE LIS CONNECTED TO THE DL2000 REPORTED THE CRP RESULT AS "< 0.5 MG/DL." IT WAS LATER DISCOVERED THAT THE SAMPLE WAS LIPEMIC BUT THAT THE TECHNICIAN HAD DILUTED THE SAMPLE AND IT HAD GIVEN RISE TO THE RESULT OBTAINED. THE RESULT WAS REPORTED TO THE PHYSICIAN BUT IT IS NOT KNOWN IF THERE WAS ANY CHANGE TO PT MANAGEMENT. THE CUSTOMER DID NOT INDICATE IF THE SAMPLE WAS RE-RUN AND DID NOT PROVIDE ANY SAMPLE DATA OR PT DATA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DATALINK/DL2000 DATA MANAGER, COMMAND CENTRAL JQP BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 UNK